The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTStructure, Recognition, and Processing of Cisplatin−DNA AdductsElizabeth R. Jamieson and Stephen J. LippardView Author Information Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 Cite this: Chem. Rev. 1999, 99, 9, 2467–2498Publication Date (Web):August 14, 1999Publication History Received29 April 1999Published online14 August 1999Published inissue 8 September 1999https://pubs.acs.org/doi/10.1021/cr980421nhttps://doi.org/10.1021/cr980421nresearch-articleACS PublicationsCopyright © 1999 American Chemical SocietyRequest reuse permissionsArticle Views13254Altmetric-Citations2491LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Adducts,Antineoplastic agents,Cells,Genetics,Peptides and proteins Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Alberts, B., Johnson, A., Lewis, J., Morgan, D., Raff, M., Roberts, K., & Walter, P. (2017) · W.W. Norton eBooks · doi:10.1201/9781315735368 · Cited by 6,365
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Telomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
A highly conserved repetitive DNA sequence,(TTAGGG) n, present at the telomeres of human chromosomes
Moyzis, R. K., Buckingham, J. M., Cram, L. S., Dani, M., Deaven, L. L., Jones, M. D., Meyne, J., Ratliff, R. L., & Wu, J. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6622 · Cited by 1,820
Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug
(1999) · Wiley eBooks · doi:10.1002/9783906390420 · Cited by 1,296
Sancar, A. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.000355 · Cited by 1,131
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
Condra, J. H., Schleif, W. A., Blahy, O. M., Gabryelski, L. J., Graham, D. J., Quintero, J., Rhodes, A., Robbins, H. L., Roth, E., Shivaprakash, M., et al. (1995) · Nature · doi:10.1038/374569a0 · Cited by 974
LOEHRER, P. J., & EINHORN, L. H. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-5-704 · Cited by 947
Structural aspects of platinum anticancer drug interactions with DNA
Sherman, S. E., & Lippard, S. J. (1987) · Chemical Reviews · doi:10.1021/cr00081a013 · Cited by 930
Self-citationGodwin, A. K., Meister, A., O'Dwyer, P. J., Huang, C. S., Hamilton, T. C., & Anderson, M. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3070 · Cited by 925
Sugasawa, K., Ng, J. M. Y., Masutani, C., Iwai, S., van der Spek, P. J., Eker, A. P. M., Hanaoka, F., Bootsma, D., & Hoeijmakers, J. H. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80132-x · Cited by 899
Lavery, R., & Sklenar, H. (1988) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.1988.10506483 · Cited by 894
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
Miyashita, T., & Reed, J. (1993) · Blood · doi:10.1182/blood.v81.1.151.151 · Cited by 882
Barry, M. A., Behnke, C. A., & Eastman, A. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90733-2 · Cited by 867
Conservation of the human telomere sequence (TTAGGG)n among vertebrates.
Meyne, J., Ratliff, R. L., & Moyzis, R. K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.7049 · Cited by 843
HMG domain proteins: architectural elements in the assembly of nucleoprotein structures
Grosschedl, R., Giese, K., & Pagel, J. (1994) · Trends in Genetics · doi:10.1016/0168-9525(94)90232-1 · Cited by 813
Takahara, P. M., Rosenzweig, A. C., Frederick, C. A., & Lippard, S. J. (1995) · Nature · doi:10.1038/377649a0 · Cited by 769
Self-citationLebwohl, D., & Canetta, R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00224-x · Cited by 754
Agarwal, M. L., Taylor, W. R., Chernov, M. V., Chernova, O. B., & Stark, G. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.1 · Cited by 726
Zlokarnik, G., Negulescu, P. A., Knapp, T. E., Mere, L., Burres, N., Feng, L., Whitney, M., Roemer, K., & Tsien, R. Y. (1998) · Science · doi:10.1126/science.279.5347.84 · Cited by 690
Overexpression of Metallothionein Confers Resistance to Anticancer Drugs
Kelley, S. L., Basu, A., Teicher, B. A., Hacker, M. P., Hamer, D. H., & Lazo, J. S. (1988) · Science · doi:10.1126/science.3175622 · Cited by 601
Cellular accumulation of the anticancer agent cisplatin: A review
Gately, D., & Howell, S. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.221 · Cited by 572
The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins
Orphanides, G., Wu, W.-H., Lane, W. S., Hampsey, M., & Reinberg, D. (1999) · Nature · doi:10.1038/22350 · Cited by 554
Role of NK1.1 + T Cells in a T H 2 Response and in Immunoglobulin E Production
Yoshimoto, T., Bendelac, A., Watson, C., Hu-Li, J., & Paul, W. E. (1995) · Science · doi:10.1126/science.270.5243.1845 · Cited by 496
Transcription-Coupled Repair and Human Disease
Hanawalt, P. C. (1994) · Science · doi:10.1126/science.7801121 · Cited by 496
Bancroft, D. P., Lepre, C. A., & Lippard, S. J. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00175a020 · Cited by 477
Self-citationWerner, M. H., Huth, J. R., Gronenborn, A. M., & Marius Clore, G. (1995) · Cell · doi:10.1016/0092-8674(95)90532-4 · Cited by 465
Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA
Eastman, A. (1986) · Biochemistry · doi:10.1021/bi00361a026 · Cited by 458
Analysis of Events Associated With Cell Cycle Arrest at G2 Phase and Cell Death Induced by Cisplatin
Sorenson, C. M., Barry, M. A., & Eastman, A. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.9.749 · Cited by 443
Duckett, D. R., Drummond, J. T., Murchie, A. I., Reardon, J. T., Sancar, A., Lilley, D. M., & Modrich, P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6443 · Cited by 421
Molecular biology of the cell (2nd edn)
Arias, A. M. (1989) · Trends in Genetics · doi:10.1016/0168-9525(89)90205-9 · Cited by 416
Crystal Structure of the Anticancer Drug Cisplatin Bound to Duplex DNA
Takahara, P. M., Frederick, C. A., & Lippard, S. J. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9625079 · Cited by 405
Self-citationNew Cisplatin Analogues in Development: A Review
Weiss, R. B., & Christian, M. C. (1993) · Drugs · doi:10.2165/00003495-199346030-00003 · Cited by 404
Apoptosis: Cell death in tissue regulation
Wyllie, A. H. (1987) · The Journal of Pathology · doi:10.1002/path.1711530404 · Cited by 390
Cellular and molecular determinants of cisplatin resistance
Perez, R. P. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00227-5 · Cited by 384
Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy
(1991) · Springer eBooks · doi:10.1007/978-1-4899-0738-7 · Cited by 374
The influence of structure on the activity and toxicity of Pt anti-cancer drugs
Hambley, T. W. (1997) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(97)00023-4 · Cited by 348
Repair of Cisplatin−DNA Adducts by the Mammalian Excision Nuclease
Zamble, D. B., Mu, D., Reardon, J. T., Sancar, A., & Lippard, S. J. (1996) · Biochemistry · doi:10.1021/bi960453+ · Cited by 333
Self-citationGorman, M. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.21.6548 · Cited by 323
High mobility group protein-1 (HMG-1) is a unique activator of p53
Jayaraman, L., Moorthy, N. C., Murthy, K. G. K., Manley, J. L., Bustin, M., & Prives, C. (1998) · Genes & Development · doi:10.1101/gad.12.4.462 · Cited by 321
Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)
Eastman, A., & Schulte, N. (1988) · Biochemistry · doi:10.1021/bi00413a022 · Cited by 312
ERCC1 and ERCC2 Expression in Malignant Tissues From Ovarian Cancer Patients
Dabholkar, M., Bostick-Bruton, F., Weber, C., Bohr, V. A., Egwuagu, C., & Reed, E. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.19.1512 · Cited by 305
Köberle, B., Masters, J. R. W., Hartley, J. A., & Wood, R. D. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80118-3 · Cited by 300
Parker, R. J., Eastman, A., Bostick-Bruton, F., & Reed, E. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115080 · Cited by 299
Drummond, J. T., Anthoney, A., Brown, R., & Modrich, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19645 · Cited by 295
Structure refined to 2Å of a nicked DNA octanucleotide complex with DNase I
Suck, D., Lahm, A., & Oefner, C. (1988) · Nature · doi:10.1038/332464a0 · Cited by 293
Bellon, S. F., Coleman, J. H., & Lippard, S. J. (1991) · Biochemistry · doi:10.1021/bi00246a021 · Cited by 291
Self-citationGelasco, A., & Lippard, S. J. (1998) · Biochemistry · doi:10.1021/bi973176v · Cited by 282
Self-citationRepair of mitochondrial DNA after various types of DNA damage in Chinese hamster ovary cells
LeDoux, S. P., Wilson, G. L., Beecham, E. J., Stevnsner, T., Wassermann, K., & Bohr, V. A. (1992) · Carcinogenesis · doi:10.1093/carcin/13.11.1967 · Cited by 269
Induction of B Cell Unresponsiveness to Noninherited Maternal HLA Antigens During Fetal Life
Claas, F. H. J., Gijbels, Y., van der Velden-de Munck, J., & van Rood, J. J. (1988) · Science · doi:10.1126/science.3051377 · Cited by 265
Majeti, R., Bilwes, A. M., Noel, J. P., Hunter, T., & Weiss, A. (1998) · Science · doi:10.1126/science.279.5347.88 · Cited by 265
Mistry, P., Kelland, L., Abel, G., Sidhar, S., & Harrap, K. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.279 · Cited by 261
Mechanisms for selecting 5′ splice sites in mammalian pre-mRNA splicing
Horowitz, D. S., & Krainer, A. R. (1994) · Trends in Genetics · doi:10.1016/0168-9525(94)90233-x · Cited by 256
Bruhn, S. L., Pil, P. M., Essigmann, J. M., Housman, D. E., & Lippard, S. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2307 · Cited by 248
Self-citationStrand-specific Mismatch Repair in Mammalian Cells
Modrich, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.24727 · Cited by 248
Brown, R., Hirst, G. L., Gallagher, W. M., McIlwrath, A. J., Margison, G. P., van der Zee, A. G., & Anthoney, D. A. (1997) · Oncogene · doi:10.1038/sj.onc.1201167 · Cited by 243
EPITAX: a computer-assisted graphical representation of the bicrystallography of general interfaces
Guillet, F., & Hagège, S. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004387 · Cited by 233
Pinto, A. L., & Lippard, S. J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.14.4616 · Cited by 219
Self-citationSequence-dependent variation in the conformation of DNA
Lomonossoff, G. P., Butler, P. J. G., & Klug, A. (1981) · Journal of Molecular Biology · doi:10.1016/0022-2836(81)90356-9 · Cited by 217
Reed, E., Ozols, R. F., Tarone, R., Yuspa, S. H., & Poirier, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.14.5024 · Cited by 217
Ciccarelli, R. B., Solomon, M. J., Varshavsky, A., & Lippard, S. J. (1985) · Biochemistry · doi:10.1021/bi00347a005 · Cited by 205
Self-citationThe mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin
Mello, J. A., Acharya, S., Fishel, R., & Essigmann, J. M. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90149-0 · Cited by 199
Coste, F., Malinge, J.-M., Serre, L., Leng, M., Zelwer, C., Shepard, W., & Roth, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.8.1837 · Cited by 199
Poklar, N., Pilch, D. S., Lippard, S. J., Redding, E. A., Dunham, S. U., & Breslauer, K. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7606 · Cited by 191
Self-citationPreferential Attack of Mitochondrial DNA by Aflatoxin B 1 During Hepatocarcinogenesis
Niranjan, B. G., Bhat, N. K., & Avadhani, N. G. (1982) · Science · doi:10.1126/science.6797067 · Cited by 190
Witkin, E. M. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.57.5.1275 · Cited by 190
Metallothionein gene expression and resistance to cisplatin in human ovarian cancer
Schilder, R. J., Hall, L., Monks, A., Handel, L. M., Fornace, A. J., Ozols, R. F., Fojo, A. T., & Hamilton, T. C. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450306 · Cited by 185
Horikoshi, N., Usheva, A., Chen, J., Levine, A. J., Weinmann, R., & Shenk, T. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.227 · Cited by 182
Pre-bending of a promoter sequence enhances affinity for the TATA-binding factor
Parvin, J. D., McCormick, R. J., Sharp, P. A., & Fisher, D. E. (1995) · Nature · doi:10.1038/373724a0 · Cited by 181
Cisplatin- and UV-damaged DNA lure the basal transcription factor TFIID/TBP
Vichi, P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.24.7444 · Cited by 172
Hardman, C. H., Broadhurst, R. W., Raine, A. R. C., Grasser, K. D., Thomas, J. O., & Laue, E. D. (1995) · Biochemistry · doi:10.1021/bi00051a007 · Cited by 168
Excision Repair in Mammalian Cells
Sancar, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.15915 · Cited by 165
Modulation of cis-diamminedichloroplatinum(II) resistance: a review
Timmer-Bosscha, H., Mulder, N., & de Vries, E. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.249 · Cited by 164
Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins
Yamada, M. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.3.491 · Cited by 161
The XPA protein is a zinc metalloprotein with an ability to recognize various kinds of DNA damage
Asahina, H., Kuraoka, I., Shirakawa, M., Morita, E. H., Miura, N., Miyamoto, I., Ohtsuka, E., Okada, Y., & Tanaka, K. (1994) · Mutation Research/DNA Repair · doi:10.1016/0921-8777(94)90034-5 · Cited by 156
Eastman, A. R., & Barry, M. A. (1987) · Biochemistry · doi:10.1021/bi00386a009 · Cited by 152
Telomere loss in cells treated with cisplatin
Ishibashi, T., & Lippard, S. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4219 · Cited by 152
Self-citationZomerdijk, J. C. B. M., Beckmann, H., Comai, L., & Tjian, R. (1994) · Science · doi:10.1126/science.7801130 · Cited by 151
p53-dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells
Zamble, D. B., Jacks, T., & Lippard, S. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6163 · Cited by 149
Self-citationBellon, S. F., & Lippard, S. J. (1990) · Biophysical Chemistry · doi:10.1016/0301-4622(90)80007-t · Cited by 148
Self-citationInhibition of telomerase activity by cisplatin in human testicular cancer cells
Burger, A. M., Double, J. A., & Newell, D. R. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00521-7 · Cited by 141
Solution structure of the DNA- and RPA-binding domain of the human repair factor XPA
Ikegami, T., Kuraoka, I., Saijo, M., Kodo, N., Kyogoku, Y., Morikawa, K., Tanaka, K., & Shirakawa, M. (1998) · Nature Structural & Molecular Biology · doi:10.1038/1400 · Cited by 139
The roles of telomeres and telomerase in cell life span
Counter, C. M. (1996) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/s0165-1110(96)90006-8 · Cited by 139
Eukaryotic mismatch repair: an update
Jiricny, J. (1998) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(98)00056-1 · Cited by 133
Donahue, B. A., Augot, M., Bellon, S. F., Treiber, D. K., TONEY, J. H., Lippard, S. J., & Essigmann, J. M. (1990) · Biochemistry · doi:10.1021/bi00476a032 · Cited by 132
Self-citationDifferential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts
Moggs, J. G., Szymkowski, D. E., Yamada, M., Karran, P., & Wood, R. D. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.3.480 · Cited by 132
Cisplatin inhibits synthesis of ribosomal RNA in vivo
Jordan, P., & Carmo‐Fonseca, M. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.12.2831 · Cited by 130
Rosenkranz, H. S., Garro, A. J., Levy, J. A., & Carr, H. S. (1966) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(66)90099-2 · Cited by 122
Szymkowski, D. E., Yarema, K. J., Essigmann, J. M., Lippard, S. J., & Wood, R. D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10772 · Cited by 115
Self-citationHistone H1 and transcription: still an enigma?
Zlatanova, J. S., & Holde, K. V. (1992) · Journal of Cell Science · doi:10.1242/jcs.103.4.889 · Cited by 115
Repair synthesis by human cell extracts in DNA damaged bycis- andtrans-diamminedichloroplatinum(II)
Hansson, J., & Wood, R. D. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.20.8073 · Cited by 114
Sequence context effects on 8-methoxypsoralen photobinding to defined DNA fragments
Sage, É., & Moustacchi, E. (1987) · Biochemistry · doi:10.1021/bi00386a010 · Cited by 112
Sheibani, N., Jennerwein, M. M., & Eastman, A. R. (1989) · Biochemistry · doi:10.1021/bi00433a055 · Cited by 107
Identification of a damaged-DNA binding domain of the XPA protein
Kuraoka, I., Morita, E. H., Saijo, M., Matsuda, T., Morikawa, K., Shirakawa, M., & Tanaka, K. (1996) · Mutation Research/DNA Repair · doi:10.1016/0921-8777(95)00038-0 · Cited by 106
Mello, J. A., Lippard, S. J., & Essigmann, J. M. (1995) · Biochemistry · doi:10.1021/bi00045a020 · Cited by 101
Self-citationZhai, X., Beckmann, H., Jantzen, H., & Essigmann, J. M. (1998) · Biochemistry · doi:10.1021/bi981708h · Cited by 100
Patrick, S. M., & Turchi, J. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.14972 · Cited by 99
Substance P Counteracts Neurotoxin Damage on Norepinephrine Neurons in Rat Brain During Ontogeny
JONSSON, G., & Hallman, H. (1982) · Science · doi:10.1126/science.6171883 · Cited by 96
Kèlland, L. R., Barnard, F. J., Evans, I. G., Murrer, B. A., Theobald, B. R. C., Wyer, S. B., Goddard, P. M., Jones, M., & Valenti, M. R. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00016a004 · Cited by 92
Ongoing and unsaid on oxaliplatin: the hope
Cvitkovic, E. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.429 · Cited by 92
Corda, Y., Job, C., Anin, M. F., Leng, M., & Job, D. (1991) · Biochemistry · doi:10.1021/bi00215a032 · Cited by 91
Kinetics and mechanism of uptake of platinum-based pharmaceuticals by the rat small intestine
Binks, S. P., & Dobrota, M. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90400-f · Cited by 91
Dunham, S. U., Dunham, S. U., Turner, C. J., & Lippard, S. J. (1998) · Journal of the American Chemical Society · doi:10.1021/ja9742592 · Cited by 87
Self-citationIdentification of p53 genetic suppressor elements which confer resistance to cisplatin
Gallagher, W. M., Cairney, M., Schott, B., Roninson, I. B., & Brown, R. H. (1997) · Oncogene · doi:10.1038/sj.onc.1200813 · Cited by 83
Trimmer, E. E., Zamble, D. B., Lippard, S. J., & Essigmann, J. M. (1998) · Biochemistry · doi:10.1021/bi971675q · Cited by 78
Self-citationPaquet, F., Pérez, C. I., Leng, M., Lancelot, G., & Malinge, J. (1996) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.1996.10508930 · Cited by 77
Dunham, S. U., & Lippard, S. J. (1997) · Biochemistry · doi:10.1021/bi9709452 · Cited by 77
Self-citationInhibition of RNA Polymerase II Transcription in Human Cell Extracts by Cisplatin DNA Damage
Cullinane, C. M., Mazur, S. J., Essigmann, J. M., Phillips, D. R., & Bohr, V. A. (1999) · Biochemistry · doi:10.1021/bi982685+ · Cited by 74
Corda, Y., Job, C., Anin, M. F., Leng, M., & Job, D. (1993) · Biochemistry · doi:10.1021/bi00084a027 · Cited by 71
Strandberg, M. C., Bresnick, E., & Eastman, A. R. (1982) · Chemico-Biological Interactions · doi:10.1016/0009-2797(82)90119-3 · Cited by 69
Oxaliplatin (L-OHP): a new reality in colorectal cancer
Bleiberg, H. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.427 · Cited by 66
Turchi, J. J., & Henkels, K. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13861 · Cited by 66
Decreased cisplatin uptake by resistant L1210 leukemia cells
Hromas, R., North, J. A., & Burns, C. P. (1987) · Cancer Letters · doi:10.1016/0304-3835(87)90091-7 · Cited by 65
Human Replication Protein A Preferentially Binds Cisplatin-Damaged Duplex DNA in Vitro
Patrick, S. M., & Turchi, J. J. (1998) · Biochemistry · doi:10.1021/bi9730590 · Cited by 63
Enhancement of Damage-Specific DNA Binding of XPA by Interaction with the ERCC1 DNA Repair Protein
Nagai, A., Saijo, M., Kuraoka, I., Matsuda, T., Kodo, N., Nakatsu, Y., Mimaki, T., Mino, M., Biggerstaff, M., Wood, R. D., et al. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1905 · Cited by 61
The major chromatin protein histone H1 binds preferentially to cis -platinum-damaged DNA
Yaneva, J. N., Leuba, S. H., Holde, K. V., & Zlatanova, J. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13448 · Cited by 60
Characterization of high mobility group protein binding to cisplatin-damaged DNA
Billings, P. C., Davis, R. J., Engelsberg, B. N., Skov, K. A., & Hughes, E. N. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91371-v · Cited by 58
Linker histones versus HMG1/2: a struggle for dominance?
Zlatanova, J. S., & Holde, K. V. (1998) · BioEssays · Cited by 58
Garderen, C. J. V., & Houte, L. P. A. V. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.1169b.x · Cited by 58
Mymryk, J. S., Zaniewski, E., & Archer, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2076 · Cited by 54
Hansson, J., Grossman, L. I., Lindahl, T. L., & Wood, R. D. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.1.35 · Cited by 52
The other function of DNA photolyase: stimulation of excision repair of chemical damage to DNA
Özer, Z., Reardon, J. T., Hsu, D. S., Malhotra, K., & Sancar, A. (1995) · Biochemistry · doi:10.1021/bi00049a002 · Cited by 49
Giurgiovich, A. J. (1997) · Carcinogenesis · doi:10.1093/carcin/18.1.93 · Cited by 48
Binding of Ixr1, a Yeast HMG-Domain Protein, to Cisplatin−DNA Adducts in Vitro and in Vivo
McA'Nulty, M. M., Whitehead, J. P., & Lippard, S. J. (1996) · Biochemistry · doi:10.1021/bi952877u · Cited by 47
Self-citationCoin, F., Frit, P., Viollet, B., Salles, B., & Egly, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3907 · Cited by 45
Naser, L. J., Pinto, A. L., Lippard, S. J., et al. (1988) · Biochemistry · doi:10.1021/bi00412a024 · Cited by 45
Self-citationMaeda, Y., Nunomura, K., & Ohtsubo, E. (1990) · Journal of Molecular Biology · doi:10.1016/s0022-2836(05)80350-x · Cited by 44
Mechanism of DNA-Dependent Protein Kinase Inhibition by cis-Diamminedichloroplatinum(II)-Damaged DNA
Turchi, J. J., Patrick, S. M., & Henkels, K. M. (1997) · Biochemistry · doi:10.1021/bi963124q · Cited by 40
BRUHN, S. L., Housman, D. E., & Lippard, S. J. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.7.1643 · Cited by 38
Self-citationAnticancer Activity of Cisplatin and Related Complexes
Gelasco, A. K., & Lippard, S. J. (1999) · Springer eBooks · doi:10.1007/978-3-662-03815-4_1 · Cited by 37
Self-citationScovell, W. M., & Kroos, L. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91435-8 · Cited by 35
Changes in the cytoskeleton pattern of tumor cells by cisplatin in vitro
Köpf‐Maier, P., & Mühlhausen, S. K. (1992) · Chemico-Biological Interactions · doi:10.1016/0009-2797(92)90002-3 · Cited by 34
Cisplatin−DNA Binding Specificity of Calf High-Mobility Group 1 Protein
Turchi, J. J., Li, M., & Henkels, K. M. (1996) · Biochemistry · doi:10.1021/bi951843j · Cited by 33
Dunham, S. U., & Lippard, S. J. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00148a012 · Cited by 33
Self-citationMiki, T., Yu, L. P. C., & Yu, C. A. (1991) · Biochemistry · doi:10.1021/bi00215a033 · Cited by 27
Fleck, O., Kunz, C., Rudolph, C., & Kohli, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30398 · Cited by 27
Giurgiovich, A. J., Anderson, L. M., Jones, A. B., Dove, L. F., Moskal, T. J., Rice, J. M., Olivero, O. A., & Poirier, M. C. (1997) · Reproductive Toxicology · doi:10.1016/s0890-6238(96)00201-8 · Cited by 25
Induction of UV-Damage Recognition Protein by Cisplatin Treatment
Vaisman, A., & Chaney, S. G. (1995) · Biochemistry · doi:10.1021/bi00001a013 · Cited by 25
Influence of chromosome integrity on Escherichia coli cell division
Markham, B. E., & Brubaker, R. R. (1980) · Journal of Bacteriology · doi:10.1128/jb.143.1.455-462.1980 · Cited by 11
Cisplatin-induced imbalances in the pattern of chimeric marker gene expression in HeLa cells
Evans, G. L., & Gralla, J. D. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91149-k · Cited by 9
Zoumpourlis, V., Kerr, D., & Spandidos, D. A. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90592-7 · Cited by 7
Cited by
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Self-citationMolecular mechanisms of cisplatin resistance
Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760
Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00597 · Cited by 2,485
Self-citationCisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Pabla, N., & Dong, Z. (2008) · Kidney International · doi:10.1038/sj.ki.5002786 · Cited by 1,918
Current Status of Platinum-Based Antitumor Drugs
Wong, E., & Giandomenico, C. M. (1999) · Chemical Reviews · doi:10.1021/cr980420v · Cited by 1,800
Metadata
- Authors
- Jamieson, E. R., & Lippard, S. J.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-08-14
- Volume
- 99
- Issue
- 9
- Pages
- 2467-2498
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2043610941
- Cited by
- 2,949
- References
- 144
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.